Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of prothrombin complex concentrate.

Di Fusco SA, Aspromonte N, Aquilani S, Mele L, Colivicchi F.

Monaldi Arch Chest Dis. 2013 Dec;80(4):184-8. Review.

2.

Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.

Schick KS, Fertmann JM, Jauch KW, Hoffmann JN.

Crit Care. 2009;13(6):R191. doi: 10.1186/cc8186. Epub 2009 Nov 30.

3.

Reversal of vitamin K antagonists prior to urgent surgery.

Grobler C, Callum J, McCluskey SA.

Can J Anaesth. 2010 May;57(5):458-67. doi: 10.1007/s12630-009-9250-3. Epub 2010 Jan 15. Review.

PMID:
20077167
4.

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Lancet. 2015 May 23;385(9982):2077-87. doi: 10.1016/S0140-6736(14)61685-8. Epub 2015 Feb 27.

PMID:
25728933
5.

An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal.

Altorjay Á, Szabó É, Boda Z, Kramer L, Ngo LY, Engl W, Firth CL, Ahlstrom ER, Gelmont DM, Pabinger I.

Thromb Res. 2015 Mar;135(3):485-91. doi: 10.1016/j.thromres.2014.12.026. Epub 2015 Jan 2.

PMID:
25613927
6.

Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.

Cruz JL, Moss MC, Chen SL, Hansen KM, Amerine LB.

Blood Coagul Fibrinolysis. 2015 Jun;26(4):378-82. doi: 10.1097/MBC.0000000000000259.

PMID:
25688457
7.

Pharmacologic interventions for reversing the effects of oral anticoagulants.

Kalus JS.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.

PMID:
23640528
8.

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Circulation. 2013 Sep 10;128(11):1234-43. doi: 10.1161/CIRCULATIONAHA.113.002283. Epub 2013 Aug 9.

9.

Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.

Le Roux P, Pollack CV Jr, Milan M, Schaefer A.

J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm. Review.

PMID:
25081496
10.

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.

Yasaka M, Sakata T, Naritomi H, Minematsu K.

Thromb Res. 2005;115(6):455-9.

PMID:
15792675
11.

Reversal of warfarin anticoagulation for urgent surgical procedures.

Curtis R, Schweitzer A, van Vlymen J.

Can J Anaesth. 2015 Jun;62(6):634-49. doi: 10.1007/s12630-015-0366-3. Epub 2015 Apr 7.

PMID:
25846343
12.

Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.

Cabral KP, Fraser GL, Duprey J, Gibbons BA, Hayes T, Florman JE, Seder DB.

Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24.

PMID:
22835715
13.

Perioperative hemostatic management of patients treated with vitamin K antagonists.

Levy JH, Tanaka KA, Dietrich W.

Anesthesiology. 2008 Nov;109(5):918-26. doi: 10.1097/ALN.0b013e3181895bd8. Review.

PMID:
18946305
14.

[Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Angelo M, Stockner I, Wiedermann CJ.

Wien Med Wochenschr. 2008;158(21-22):615-20. doi: 10.1007/s10354-008-0610-3. Review. German.

PMID:
19052707
15.

Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.

Sarode R.

Clin Lab Med. 2014 Sep;34(3):613-21. doi: 10.1016/j.cll.2014.06.002. Epub 2014 Jul 23. Review.

PMID:
25168946
16.

Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.

Imberti D, Magnacavallo A, Dentali F, Condoleo E, Gallerani M, Benedetti R, Ageno W.

J Thromb Thrombolysis. 2013 Jul;36(1):102-8. doi: 10.1007/s11239-012-0817-4.

PMID:
23054464
17.

New strategies for effective treatment of vitamin K antagonist-associated bleeding.

Yates SG, Sarode R.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S180-6. doi: 10.1111/jth.12970. Review.

PMID:
26149021
18.

Warfarin-induced bleeding complications - clinical presentation and therapeutic options.

Wiedermann CJ, Stockner I.

Thromb Res. 2008;122 Suppl 2:S13-8. doi: 10.1016/S0049-3848(08)70004-5. Review.

PMID:
18549907
19.

Low-dose 3-factor prothrombin complex concentrate for warfarin reversal prior to heart transplant.

Kantorovich A, Fink JM, Militello MA, Wanek MR, Smedira NG, Soltesz EG, Moazami N.

Ann Pharmacother. 2015 Aug;49(8):876-82. doi: 10.1177/1060028015585344. Epub 2015 May 18.

PMID:
25986007
20.

Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.

Leissinger CA, Blatt PM, Hoots WK, Ewenstein B.

Am J Hematol. 2008 Feb;83(2):137-43. Review.

Items per page

Supplemental Content

Write to the Help Desk